Skip to main content

‹‹‹ prev (25)

(27) next ›››

(26)
24 —
or territory unless and until it has been ascertained to the satisfac¬
tion of the government concerned that the product in question is
of medical or scientific value.
In this case (unless the government determines that the product
is not capable of producing addiction or of conversion into a product
capable of producing addiction) the quantities permitted to be
manufactured, pending the decision hereinafter referred to, shall
not exceed the total of the domestic requirements of the country
or territory for medical and scientific needs and the quantity
required for export orders, and the provisions of this convention
shall apply.
2. Any High Contracting Party permitting trade in or manu¬
facture for trade of any such product to be commenced shall imme¬
diately send a notification to that effect to the Secretary General
of the League of Nations, who shall advise the other High Con¬
tracting Parties and the Health Committee of the League.
3. The Health Committee will thereupon, after consulting the
Permanent Committee of the Office international d’Hygiene publi-
que, decide whether the product in question is capable of producing
addiction (and is in consequence assimilable to the drugs men¬
tioned in Sub-group (a) of Group I), or whether it is convertible
into such a drug (and is in consequence assimilable to the drugs
mentioned in Sub-Group (6) of Group I or in Group II).
4. In the event of the Health Committee deciding that the pro¬
duct is not itself a drug capable of producing addiction, but is con¬
vertible into such a drug, the question whether the drug in question
shall fall under Sub-group (6) of Group I or under Group II shall
be referred for decision to a body of three experts competent to
deal with the scientific and technical aspects of the matter, of whom
one member shall be selected by the government concerned, one
by the Opium Advisory Committee of the League, and the third
by the two members so selected.
5. Any decision arrived at in accordance with the two preceding
paragraphs shall be notified to the Secretary General of the League
of Nations, who will communicate it to all the members of the
League of Nations and to the non-member states mentioned in
article 27.1
6. If the decisions are to the effect that the product in question
is capable of producing addiction or is convertible into a drug
producing addiction, the High Contracting Parties will, upon
receipt of the communication from the Secretary General, apply
1 See footnote on p. 21.

Images and transcriptions on this page, including medium image downloads, may be used under the Creative Commons Attribution 4.0 International Licence unless otherwise stated. Creative Commons Attribution 4.0 International Licence